Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
Figure 10
Three months later, the BCVA was 20/80, and although the condition of the fundus eye had improved (a), there was a great PED at FA and cirrus HD-OCT ((c) and (d)) with persistence of the polypoid lesion in the ICGA and cirrus HD-OCT ((f) and (d)), which led to a new PDT session on the polyp (spot size 1500 microns).